The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Uber claims the L.A. law firms sent people involved in accidents with Uber drivers to certain medical groups for unnecessary ...

Roche’s IgG2 monoclonal antibody (mAb) astegolimab has yielded mixed results in chronic obstructive pulmonary disease (COPD), ...

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...

The project, launched in June 2024 and set for full operation in mid-2026, has received strong backing from local authorities ...

Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm ...

In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage performance of its anti-TIGIT antibody belrestotug.

J ACKSON COUNTY, Kan. (WIBW) - Two people were arrested for possession of meth following a traffic infraction on Wednesday, ...

Like going to the supermarket and staring at aisles of cereal and sauces, the average ChatGPT user is currently faced with an ...